Neonc Technologies Holdings, Inc. SEC filings NTHI
Neonc Technologies Holdings, Inc. has 206 filings in SEC EDGAR's recent list, going back to Jun 22, 2023. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 22, 2026 | Oct 16, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 15, 2026 | Oct 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 28, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 21, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 17, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 10, 2026 | Sep 8, 2026 |
| 424B5 | Prospectus supplement | Sep 10, 2026 | — |
| 8-K/A |
Amended current report
Officer or director change
|
Aug 21, 2026 | Jun 27, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Aug 20, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 13, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 10, 2026 | Aug 10, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 15, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2026 | Jun 27, 2026 |
| D | Filing | Jun 25, 2026 | — |
| EFFECT | Filing | Jun 23, 2026 | — |
| DEFA14A | Additional proxy material | Jun 23, 2026 | — |
| DEF 14A | Proxy statement | Jun 23, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 23, 2026 | Jun 23, 2026 |
| 424B5 | Prospectus supplement | Jun 23, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2026 | Jun 16, 2026 |
| S-3 | Shelf registration | Jun 15, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
Jun 12, 2026 | Jun 10, 2026 |
| PRE 14A | Preliminary proxy statement | Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 18, 2026 | May 18, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K/A | Amended annual report | May 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 24, 2026 | Apr 20, 2026 |
| EFFECT | Filing | Apr 16, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 16, 2026 | Apr 14, 2026 |
| 424B5 | Prospectus supplement | Apr 16, 2026 | — |
| CORRESP | Letter to the SEC | Apr 14, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2026 | — |
| S-3 | Shelf registration | Apr 10, 2026 | — |
| 8-K |
Current report
Material agreement
|
Apr 10, 2026 | Apr 10, 2026 |
| 424B5 | Prospectus supplement | Apr 10, 2026 | — |
| EFFECT | Filing | Apr 9, 2026 | — |
| CORRESP | Letter to the SEC | Apr 7, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 3, 2026 | Apr 1, 2026 |
| S-3 | Shelf registration | Apr 2, 2026 | — |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 23, 2026 | Mar 20, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Mar 17, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 6, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Other events
|
Mar 4, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 3, 2026 | Feb 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 27, 2026 | Feb 27, 2026 |
| EFFECT | Filing | Feb 12, 2026 | — |
| 424B5 | Prospectus supplement | Feb 12, 2026 | — |
| CORRESP | Letter to the SEC | Feb 10, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2026 | — |
| D | Filing | Feb 9, 2026 | — |
| S-1 | Registration statement | Feb 6, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 29, 2026 | Jan 29, 2026 |
| EFFECT | Filing | Dec 23, 2025 | — |
| 424B5 | Prospectus supplement | Dec 23, 2025 | — |
| CORRESP | Letter to the SEC | Dec 19, 2025 | — |
| D | Filing | Dec 18, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 17, 2025 | Dec 15, 2025 |
| S-1 | Registration statement | Dec 15, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 5, 2025 | Dec 1, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 14, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 424B4 | Prospectus | Nov 13, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 10, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 6, 2025 | Oct 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 30, 2025 | Oct 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2025 | Oct 6, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 9, 2025 | Oct 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Results of operations, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Aug 22, 2025 | Aug 18, 2025 |
| UPLOAD | Letter from the SEC | Aug 20, 2025 | — |
| 8-K/A |
Amended current report
Restatement
|
Aug 20, 2025 | Aug 13, 2025 |
| UPLOAD | Letter from the SEC | Aug 19, 2025 | — |
| 10-Q | Quarterly report | Aug 18, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Restatement
|
Aug 18, 2025 | Aug 13, 2025 |
| NT 10-Q | Filing | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 13, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 1, 2025 | Jul 28, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 30, 2025 | Jul 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 25, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 22, 2025 | Jul 16, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 10, 2025 | Jul 8, 2025 |
| EFFECT | Filing | Jun 16, 2025 | — |
| 424B5 | Prospectus supplement | Jun 16, 2025 | — |
| CORRESP | Letter to the SEC | Jun 12, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 12, 2025 | Jun 6, 2025 |
| UPLOAD | Letter from the SEC | Jun 12, 2025 | — |
| S-1 | Registration statement | Jun 6, 2025 | — |
| 8-K |
Current report
Material agreement, Officer or director change
|
Jun 6, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 3, 2025 | May 28, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| EFFECT | Filing | May 6, 2025 | — |
| 424B5 | Prospectus supplement | May 6, 2025 | — |
| CORRESP | Letter to the SEC | May 2, 2025 | — |
| UPLOAD | Letter from the SEC | May 2, 2025 | — |
| S-1 | Registration statement | Apr 29, 2025 | — |
| D | Filing | Apr 11, 2025 | — |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Apr 11, 2025 | Apr 7, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Apr 1, 2025 | Mar 26, 2025 |
| 8-K |
Current report
Auditor change
|
Apr 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Mar 27, 2025 | Mar 25, 2025 |
| CERT | Filing | Mar 26, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| S-8 | Employee stock plan registration | Mar 25, 2025 | — |
| 424B4 | Prospectus | Mar 25, 2025 | — |
| 8-A12B | Filing | Mar 24, 2025 | — |
| D | Filing | Mar 24, 2025 | — |
| CORRESP | Letter to the SEC | Mar 21, 2025 | — |
| S-1/A | Amended registration statement | Feb 26, 2025 | — |
| CORRESP | Letter to the SEC | Feb 26, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2025 | — |
| S-1/A | Amended registration statement | Jan 31, 2025 | — |
| CORRESP | Letter to the SEC | Jan 30, 2025 | — |
| S-1 | Registration statement | Jan 3, 2025 | — |
| CORRESP | Letter to the SEC | Jan 2, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2024 | — |
| DRS/A | Filing | Dec 10, 2024 | — |
| CORRESP | Letter to the SEC | Dec 9, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 27, 2024 | — |
| DRS | Filing | Oct 29, 2024 | — |
| D | Filing | Oct 28, 2024 | — |
| RW | Filing | Jun 12, 2024 | — |
| FWP | Free writing prospectus | Mar 1, 2024 | — |
| S-1/A | Amended registration statement | Mar 1, 2024 | — |
| S-1/A | Amended registration statement | Feb 23, 2024 | — |
| S-1/A | Amended registration statement | Feb 5, 2024 | — |
| S-1/A | Amended registration statement | Jan 16, 2024 | — |
| S-1 | Registration statement | Dec 18, 2023 | — |
| DRS/A | Filing | Sep 27, 2023 | — |
| DRS/A | Filing | Aug 9, 2023 | — |
| D | Filing | Jul 5, 2023 | — |
| DRS | Filing | Jun 22, 2023 | — |
Showing 137 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NTHI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Calabasas, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1979414
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.